A. Holzmann et al., HYPORESPONSIVENESS TO INHALED NITRIC-OXIDE IN ISOLATED, PERFUSED LUNGS FROM ENDOTOXIN-CHALLENGED RATS, American journal of physiology. Lung cellular and molecular physiology, 15(6), 1996, pp. 981-986
Inhaled nitric oxide (iNO) causes selective pulmonary vasodilation and
improves oxygenation in patients with the adult respiratory distress
syndrome (ARDS). Approximately 30% of ARDS patients fail to respond to
iNO. Because sepsis syndrome often accompanies a decreased response t
o iNO, we investigated NO responsiveness in isolated, perfused lungs f
rom rats exposed to lipopolysaccharide (LPS). Eighteen hours after int
raperitoneal injection of 0.5 mg/kg LPS, rat lungs were isolated, perf
used, and preconstricted with U-46619. Ventilation with 0.4, 4, and 40
parts per million by volume NO vasodilated LPS-pretreated lungs 75, 4
7, and 42% less than control lungs (P < 0.01 value differs at each con
centration). The diminished vasodilatory response to iNO was associate
d with decreased NO-stimulated guanosine 3',5'-cyclic monophosphate (c
GMP) release into the perfusate. Soluble guanylate cyclase activity di
d not differ in lung extracts from LPS-pretreated and control rats. LP
S increased pulmonary cGMP-phosphodiesterase (PDE) activity by 40%. Th
e PDE-sensitive cGMP analogue 8-bromoguanosine 3',5'-cyclic monophosph
ate vasodilated lungs from LPS-pretreated rats less than lungs from co
ntrol rats. In contrast, the PDE-insensitive 8-para-chlorophenylthiogu
anosine 3',5'-cyclic monophosphate vasodilated lungs equally from both
groups. After LPS challenge, the rat pulmonary vasculature becomes hy
poresponsive to iNO. Hyporesponsiveness to iNO appears partly attribut
able to increased pulmonary cGMP-PDE activity.